1. Home
  2. GOVX
  3. GOVX News

Latest GeoVax Labs Inc. (GOVX) News on April 2, 2025

Geovax Labs Inc (GOVX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial ...
GOVX

GuruFocus.com

5 days ago

Geovax Labs Inc (GOVX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial ...

GeoVax Reports 2024 Year-End Financial Results and Provides Business Update
GOVX

NewMediaWire

5 days ago

GeoVax Reports 2024 Year-End Financial Results and Provides Business Update

Presenting on the Emerging Growth Conference 80, Day 1 on March 26 - Register Now
GOVX

GlobeNewswire

8 days ago

Presenting on the Emerging Growth Conference 80, Day 1 on March 26 - Register Now

GeoVax Labs Announces $4.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GOVX

NewMediaWire

9 days ago

GeoVax Labs Announces $4.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GeoVax to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on March 27, 2025
GOVX

NewMediaWire

16 days ago

GeoVax to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on March 27, 2025

GeoVax Establishing Strategic Presence in Europe With Initial Footprint in the UK
GOVX

NewMediaWire

21 days ago

GeoVax Establishing Strategic Presence in Europe With Initial Footprint in the UK

GeoVax to Present at the 37th Annual Roth Conference
GOVX

NewMediaWire

22 days ago

GeoVax to Present at the 37th Annual Roth Conference

Registration is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event MPOX 2025: Navigating the Global Public Health Emergency Featuring GeoVax CEO On March 6, 2025
GOVX

NewMediaWire

a month ago

Registration is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event MPOX 2025: Navigating the Global Public Health Emergency Featuring GeoVax CEO On March 6, 2025

GeoVax Highlights the Critical Role of MVA-Based Vaccines in U.S. Biodefense Strategy
GOVX

NewMediaWire

a month ago

GeoVax Highlights the Critical Role of MVA-Based Vaccines in U.S. Biodefense Strategy

GeoVax Response to WHO's Third Declaration of Mpox as a Public Health Emergency of International Concern
GOVX

NewMediaWire

a month ago

GeoVax Response to WHO's Third Declaration of Mpox as a Public Health Emergency of International Concern

GeoVax Highlights the Role of MVA-Based Vaccines in Advancing Public Health Preparedness
GOVX

NewMediaWire

a month ago

GeoVax Highlights the Role of MVA-Based Vaccines in Advancing Public Health Preparedness

Mpox Clade 1 in the U.S. Highlights the Need for Vaccine Supply Diversification
GOVX

NewMediaWire

a month ago

Mpox Clade 1 in the U.S. Highlights the Need for Vaccine Supply Diversification

Presenting on the Emerging Growth Conference 79 Day 2 on February 19 Register Now
GOVX

GlobeNewswire

a month ago

Presenting on the Emerging Growth Conference 79 Day 2 on February 19 Register Now

GeoVax Pledges Continued Support for Vaccine Innovation, Transparency, and Public Health
GOVX

NewMediaWire

a month ago

GeoVax Pledges Continued Support for Vaccine Innovation, Transparency, and Public Health

GeoVax to Present at the Emerging Growth Conference on February 19, 2025
GOVX

NewMediaWire

a month ago

GeoVax to Present at the Emerging Growth Conference on February 19, 2025

GeoVax Congratulates Dr. Valerie Montgomery Rice on Receiving the 2025 Healthcare Champions Lifetime Achievement Award
GOVX

NewMediaWire

2 months ago

GeoVax Congratulates Dr. Valerie Montgomery Rice on Receiving the 2025 Healthcare Champions Lifetime Achievement Award

GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs
GOVX

NewMediaWire

2 months ago

GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs

GeoVax to Showcase Advancements in Vaccines & Immunotherapies at the 2025 BIO CEO & Investor Conference
GOVX

NewMediaWire

2 months ago

GeoVax to Showcase Advancements in Vaccines & Immunotherapies at the 2025 BIO CEO & Investor Conference

GeoVax Announces Strategic Integration of AI in Support of President Trump's Stargate Initiative
GOVX

NewMediaWire

2 months ago

GeoVax Announces Strategic Integration of AI in Support of President Trump's Stargate Initiative

Strengthening America's Biosecurity: GeoVax Advances Domestic Vaccine Capability
GOVX

NewMediaWire

2 months ago

Strengthening America's Biosecurity: GeoVax Advances Domestic Vaccine Capability

GeoVax Advanced MVA Manufacturing Process: Aimed to Enhance Vaccine Supply Worldwide
GOVX

NewMediaWire

2 months ago

GeoVax Advanced MVA Manufacturing Process: Aimed to Enhance Vaccine Supply Worldwide

GeoVax Announces Major Gedeptin Milestone With Plans of Phase 2 Trial
GOVX

NewMediaWire

3 months ago

GeoVax Announces Major Gedeptin Milestone With Plans of Phase 2 Trial

Presenting on the Emerging Growth Conference 78 Day 2 on January 16 Register Now
GOVX

GlobeNewswire

3 months ago

Presenting on the Emerging Growth Conference 78 Day 2 on January 16 Register Now

GeoVax Achieves Significant Progress in Next-Generation COVID-19 Vaccine Development Throughout 2024
GOVX

NewMediaWire

3 months ago

GeoVax Achieves Significant Progress in Next-Generation COVID-19 Vaccine Development Throughout 2024

GeoVax to Review 2024 Progress at the Emerging Growth Conference on January 16, 2025
GOVX

NewMediaWire

3 months ago

GeoVax to Review 2024 Progress at the Emerging Growth Conference on January 16, 2025

GeoVax to Review 2024 Progress at Biotech Showcase During J.P. Morgan Healthcare Week 2025
GOVX

NewMediaWire

3 months ago

GeoVax to Review 2024 Progress at Biotech Showcase During J.P. Morgan Healthcare Week 2025

GeoVax Receives Notice of Allowance For Cancer Vaccine Patent
GOVX

GlobeNewswire

4 months ago

GeoVax Receives Notice of Allowance For Cancer Vaccine Patent

GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference
GOVX

GlobeNewswire

4 months ago

GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference

GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia
GOVX

GlobeNewswire

4 months ago

GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia

Geovax Labs Inc (GOVX) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Challenges
GOVX

GuruFocus.com

5 months ago

Geovax Labs Inc (GOVX) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Challenges

GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update
GOVX

GlobeNewswire

5 months ago

GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update

GeoVax Labs initiated with a Buy at Alliance Global Partners
GOVX

TipRanks

5 months ago

GeoVax Labs initiated with a Buy at Alliance Global Partners

GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024
GOVX

GlobeNewswire

5 months ago

GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024

Geovax Labs Inc (GOVX) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial ...
GOVX

GuruFocus.com

6 months ago

Geovax Labs Inc (GOVX) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial ...

GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
GOVX

GlobeNewswire

6 months ago

GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now
GOVX

GlobeNewswire

6 months ago

Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now

GeoVax Labs, Inc. (GOVX): A Hot Penny Stock On The Move
GOVX

Insider Monkey

7 months ago

GeoVax Labs, Inc. (GOVX): A Hot Penny Stock On The Move

GeoVax to Participate in Upcoming Investor Conferences in September
GOVX

GlobeNewswire

7 months ago

GeoVax to Participate in Upcoming Investor Conferences in September

GOVX

MT Newswires

7 months ago

GeoVax Labs Enters Deal to Raise $5 Million in Equity Offering

GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market
GOVX

GlobeNewswire

7 months ago

GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market

Should You Buy GeoVax Labs Inc. (GOVX) After Golden Cross?
GOVX

Zacks

7 months ago

Should You Buy GeoVax Labs Inc. (GOVX) After Golden Cross?

Registration is Now Open for Tribe Public’s Webinar Event "Now Is Not the Time to Monkey(pox) Around" Featuring GeoVax Lab’s CEO
GOVX

GlobeNewswire

7 months ago

Registration is Now Open for Tribe Public’s Webinar Event "Now Is Not the Time to Monkey(pox) Around" Featuring GeoVax Lab’s CEO

GOVX

MT Newswires

7 months ago

GeoVax Labs Raises $8.5 Million Through in Direct Offering of 1.7 Million Shares

GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market
GOVX

GlobeNewswire

7 months ago

GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now
GOVX

GlobeNewswire

7 months ago

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

WHO declares mpox a public health emergency as variant emerges
GOVX

Yahoo Finance Video

7 months ago

WHO declares mpox a public health emergency as variant emerges

Mpox Worries Have Sent This Microcap Stock Sky High
GOVX

Barrons.com

7 months ago

Mpox Worries Have Sent This Microcap Stock Sky High

GeoVax to Present at the Emerging Growth Conference on August 21, 2024
GOVX

GlobeNewswire

8 months ago

GeoVax to Present at the Emerging Growth Conference on August 21, 2024

GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board
GOVX

GlobeNewswire

8 months ago

GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board

GeoVax Reports Second Quarter 2024 Financial Results and Provides Business Update
GOVX

GlobeNewswire

8 months ago

GeoVax Reports Second Quarter 2024 Financial Results and Provides Business Update

Update: GeoVax Announces Phase 2 Plans for Gedeptin® Cancer Therapy Following Clinical Advisory Committee Review
GOVX

GlobeNewswire

8 months ago

Update: GeoVax Announces Phase 2 Plans for Gedeptin® Cancer Therapy Following Clinical Advisory Committee Review

GeoVax Announces Phase 2 Plans for Gedeptin® Cancer Therapy Following Clinical Advisory Committee Review
GOVX

GlobeNewswire

8 months ago

GeoVax Announces Phase 2 Plans for Gedeptin® Cancer Therapy Following Clinical Advisory Committee Review

GeoVax to Report Second Quarter 2024 Financial Results and Provide Corporate Update on August 6, 2024
GOVX

GlobeNewswire

8 months ago

GeoVax to Report Second Quarter 2024 Financial Results and Provide Corporate Update on August 6, 2024

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now
GOVX

GlobeNewswire

9 months ago

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now

GeoVax to Present at the Emerging Growth Conference on July 18, 2024
GOVX

NewMediaWire

9 months ago

GeoVax to Present at the Emerging Growth Conference on July 18, 2024

GOVX

MT Newswires

9 months ago

Top Premarket Gainers

GeoVax to Raise Approximately $3.1 Million of Gross Proceeds in Offering Priced At-the-Market
GOVX

NewMediaWire

9 months ago

GeoVax to Raise Approximately $3.1 Million of Gross Proceeds in Offering Priced At-the-Market

GeoVax Provides First Half 2024 Business Update
GOVX

NewMediaWire

9 months ago

GeoVax Provides First Half 2024 Business Update

GeoVax Partners with Allucent to Conduct Phase 2b Clinical Study of Next-Generation COVID-19 Vaccine Candidate with Funding from BARDA
GOVX

NewMediaWire

9 months ago

GeoVax Partners with Allucent to Conduct Phase 2b Clinical Study of Next-Generation COVID-19 Vaccine Candidate with Funding from BARDA

GeoVax Receives BARDA Project NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation COVID-19 Vaccine Candidate, GEO-CM04S1
GOVX

NewMediaWire

9 months ago

GeoVax Receives BARDA Project NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation COVID-19 Vaccine Candidate, GEO-CM04S1

GOVX

MT Newswires

10 months ago

Top Premarket Decliners

GeoVax to Present at BIO International Convention 2024
GOVX

NewMediaWire

10 months ago

GeoVax to Present at BIO International Convention 2024

GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market
GOVX

NewMediaWire

a year ago

GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market

GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
GOVX

NewMediaWire

a year ago

GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update

GeoVax to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
GOVX

NewMediaWire

a year ago

GeoVax to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024

GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine
GOVX

NewMediaWire

a year ago

GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine

GeoVax to Present Data on GEO-CM04S1, A Next Generation Covid-19 Vaccine, at the World Vaccine Congress
GOVX

NewMediaWire

a year ago

GeoVax to Present Data on GEO-CM04S1, A Next Generation Covid-19 Vaccine, at the World Vaccine Congress

GeoVax to Present at the 36th Annual Roth Conference
GOVX

GlobeNewswire

a year ago

GeoVax to Present at the 36th Annual Roth Conference

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
GOVX

GlobeNewswire

a year ago

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System

GeoVax Labs, Inc. (NASDAQ:GOVX) Q4 2023 Earnings Call Transcript
GOVX

Insider Monkey

a year ago

GeoVax Labs, Inc. (NASDAQ:GOVX) Q4 2023 Earnings Call Transcript

GeoVax Reports 2023 Year-End Financial Results and Provides Business Update
GOVX

NewMediaWire

a year ago

GeoVax Reports 2023 Year-End Financial Results and Provides Business Update

GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024
GOVX

GlobeNewswire

a year ago

GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024

GeoVax to Present at the 2024 BIO CEO & Investor Conference
GOVX

GlobeNewswire

a year ago

GeoVax to Present at the 2024 BIO CEO & Investor Conference

GeoVax Announces Multiple Patent Issuances and Allowances
GOVX

GlobeNewswire

a year ago

GeoVax Announces Multiple Patent Issuances and Allowances

GeoVax Announces Multiple Patent Issuances and Allowances
GOVX

NewMediaWire

a year ago

GeoVax Announces Multiple Patent Issuances and Allowances

GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster
GOVX

NewMediaWire

a year ago

GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster

New Strong Buy Stocks for January 31st
GOVX

Zacks

a year ago

New Strong Buy Stocks for January 31st

Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
GOVX

GlobeNewswire

a year ago

Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

GOVX

GlobeNewswire

a year ago

Blue World Acquisition Corporation Announces Liquidation of Investments Held in the Trust Account into Cash

GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement
GOVX

GlobeNewswire

a year ago

GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement

3 Struggling Stocks That Can Rise Between 83% and 264%, According to Wall Street
GOVX

Motley Fool

a year ago

3 Struggling Stocks That Can Rise Between 83% and 264%, According to Wall Street

Investors in Sensus Healthcare (NASDAQ:SRTS) from a year ago are still down 60%, even after 24% gain this past week
GOVX

Simply Wall St.

a year ago

Investors in Sensus Healthcare (NASDAQ:SRTS) from a year ago are still down 60%, even after 24% gain this past week

Air Industries Group Receives Two Strategically Important New Contracts from New Customers
GOVX

Business Wire

a year ago

Air Industries Group Receives Two Strategically Important New Contracts from New Customers

When Will Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Become Profitable?
GOVX

Simply Wall St.

a year ago

When Will Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Become Profitable?

GDC’s Exploring the Evolution of AI Influencers: From TikTok Storytelling to Instagram Allure
GOVX

GlobeNewswire

a year ago

GDC’s Exploring the Evolution of AI Influencers: From TikTok Storytelling to Instagram Allure

Trust Stamp announces the continued growth of its patent portfolio for AI-powered biometric technology
GOVX

GlobeNewswire

a year ago

Trust Stamp announces the continued growth of its patent portfolio for AI-powered biometric technology

NEXGEL to Present at The Microcap Conference, January 30th through February 1st
GOVX

GlobeNewswire

a year ago

NEXGEL to Present at The Microcap Conference, January 30th through February 1st

This LiqTech International Insider Increased Their Holding In The Last Year
GOVX

Simply Wall St.

a year ago

This LiqTech International Insider Increased Their Holding In The Last Year

NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024
GOVX

GlobeNewswire

a year ago

NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024

5 Small-Cap Stocks to Play the January Effect
GOVX

Zacks

a year ago

5 Small-Cap Stocks to Play the January Effect

GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology
GOVX

NewMediaWire

a year ago

GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology

GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology
GOVX

GlobeNewswire

a year ago

GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology

GOVX

Business Wire

a year ago

Polished.com Has Scheduled its Annual Meeting of Stockholders for January 30, 2024

Kernel Group Holdings, Inc. Confirms Funding to Extend Period to Consummate Initial Business Combination
GOVX

GlobeNewswire

a year ago

Kernel Group Holdings, Inc. Confirms Funding to Extend Period to Consummate Initial Business Combination

GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients
GOVX

GlobeNewswire

a year ago

GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients

GeoVax Announces Issuance of Malaria Vaccine Patent
GOVX

GlobeNewswire

a year ago

GeoVax Announces Issuance of Malaria Vaccine Patent

GOVX

GlobeNewswire

a year ago

Blue World Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination

ReTo Eco-Solutions, Inc. Announces First Half 2023 Financial Results
GOVX

PR Newswire

a year ago

ReTo Eco-Solutions, Inc. Announces First Half 2023 Financial Results

GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024
GOVX

GlobeNewswire

a year ago

GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024

Alliance Entertainment Announces Closing of New 3-Year $120 Million Senior Secured Credit Facility
GOVX

GlobeNewswire

a year ago

Alliance Entertainment Announces Closing of New 3-Year $120 Million Senior Secured Credit Facility

Share on Social Networks: